Biondvax Pharma ADR (BVXV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BVXV | AMGN | BMY | VRTX | GILD |
| Company | Biondvax Pharma ADR | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.3200 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 1.3700 | 291.11 | 58.48 | 455.43 | 89.94 |
| Low | 1.3200 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 1.3600 | 289.90 | 58.23 | 450.37 | 89.76 |
| Change | +0.0500 | +2.03 | +0.35 | -0.86 | +1.13 |
| % Change | +3.82% | +0.71% | +0.60% | -0.19% | +1.27% |
| Volume | 23,000 | 3,284,042 | 7,412,206 | 1,493,122 | 3,897,672 |
| 20-Day Average Volume | 12,760 | 2,909,397 | 12,396,915 | 1,345,056 | 7,521,153 |
| Previous Close | 1.3100 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3207 | 307.42 | 55.92 | 479.24 | 90.89 |
| 20-Day Raw Stochastic | 78.57% | 27.22% | 69.26% | 7.17% | 28.71% |
| 20-Day Relative Strength | 49.42% | 36.50% | 60.71% | 40.89% | 53.58% |
| Weighted Alpha | -64.90 | +1.92 | +26.05 | +18.06 | +26.07 |
| Today's Opinion | 88% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 100% Sell | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 08/29/23 | -2.04% since 11/14/24 | -0.46% since 11/14/24 | -6.94% since 11/14/24 | -2.55% since 11/14/24 |
| Low | 1.3000 on 09/01/23 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 1.3700 on 09/06/23 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | -1.45% since 08/04/23 | -8.47% since 10/21/24 | +11.72% since 10/21/24 | -5.80% since 10/21/24 | +4.02% since 10/21/24 |
| Low | 1.2500 on 08/22/23 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 85.60 on 10/22/24 |
| High | 1.3900 on 08/28/23 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -5.00% since 06/06/23 | -11.92% since 08/21/24 | +20.21% since 08/21/24 | -7.35% since 08/21/24 | +19.47% since 08/21/24 |
| Low | 1.2500 on 08/22/23 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.00 on 11/21/24 | 75.35 on 08/22/24 |
| High | 1.8703 on 07/12/23 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -40.09% since 03/06/23 | -7.92% since 05/21/24 | +37.76% since 05/21/24 | +1.89% since 05/21/24 | +33.39% since 05/21/24 |
| Low | 1.2500 on 08/22/23 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 2.4400 on 04/17/23 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,540 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 1,868 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -5,800,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -3,760,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 2.37 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.11 on 08/11/23 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 08/24/23 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |